Sign In
Buy TLT
$85.31
-0.340 (-0.397%)
At Close: Jun 03, 2026
Treasury Yields: A Long-Term Perspective – June 2024
11:33am, Monday, 01'st Jul 2024
This article looks at a long-term perspective on Treasury yields. The chart below shows the 10-year constant-maturity yield since 1962 along with the Fed funds rate (FFR) and inflation.
5 Stocks I Sold Due To "Fragile Stagflation" Risk
07:21am, Friday, 28'th Jun 2024
Fragile stagflation presents challenges for investors, with limited opportunities for good returns in stocks and bonds. It is likely markets will experience a lost decade in real terms when measured f
U.S. Weekly Fund Flows Insight Report: Equity ETFs See Their Third Outflow Over The Last 4 Weeks
04:00am, Friday, 28'th Jun 2024
During LSEG Lipper's fund flows week that ended June 19, 2024, investors were overall net redeemers of fund assets for the first week in three, removing a net $30.0 billion. Taxable bond funds, altern
S&P 500 Snapshot: Index Improves for Third Straight Week
11:03am, Monday, 24'th Jun 2024
The S&P 500 rose for a third straight week, finishing up 0.61% from last Friday. The index is currently up 15.22% year to date and has recorded a new all-time high 31 times this year.
Junk bonds are beating the broader market so far in 2024 — but watch this shift
07:00am, Saturday, 22'nd Jun 2024
Junk bonds are beating the broader U.S. fixed-income market so far in 2024 — but pummeled Treasurys have attempted a comeback lately.
TLT: Bonds Offer Favorable Odds Now
12:58pm, Tuesday, 18'th Jun 2024
TLT offers exposure to long-term U.S. Treasury bonds with extended duration. TLT provides a favorable return/risk profile under current conditions. The current inflation data and future contracts both
TLT: 4 Reasons To Remain Bullish
09:32am, Tuesday, 18'th Jun 2024
TLT may face near-term volatility due to inflation and economic data, but long-term trajectory could be impacted by treasuries issuance and demand. Inflation is slowing down, with the Fed conservative
TLT Appears To Be Breaking Out
03:27pm, Monday, 17'th Jun 2024
Bullish evidence from technical analysis and fundamental reasons suggest bonds are poised for gains as the economy slows and the Fed leans towards cuts. TLT is a good fund to position for the rally du
U.S. Weekly FundFlows Insight Report: S&P 500 Index Funds See Largest Weekly Outflow On Record
01:40pm, Monday, 17'th Jun 2024
During LSEG Lipper's fund-flows week that ended June 12, 2024, investors were overall net purchasers of fund assets (including both conventional funds and ETFs) for the seventh week in eight, adding a
Invest In A SWAN Strategy: 5% Income, Lower Volatility, Solid Growth
09:00am, Saturday, 15'th Jun 2024
The SWAN (Sleep Well At Night) strategy in the financial world usually means you invest in a strategy and not have to worry about it on a day-to-day basis. We do not consider investing in the S&P 500
S&P 500 Snapshot: Climbs 1.6% From Last Week
04:57pm, Friday, 14'th Jun 2024
The S&P 500 rose for a second straight week, finishing up 1.58% from last Friday. The index is currently up 14.52% year to date and has recorded a new all-time high 29 times this year.
Treasury Yields Snapshot: June 14, 2024
04:57pm, Friday, 14'th Jun 2024
The yield on the 10-year note ended June 14, 2024 at 4.20%, the 2-year note ended at 4.67%, and the 30-year at 4.34%. Here is a table showing the yields' highs and lows and the FFR since 2007.
Wall Street Is Wrestling With What Happens Next!
01:42pm, Friday, 14'th Jun 2024
Investors know the Federal Reserve WON'T cut rates when this week's policy meeting wraps up on Wednesday. But that doesn't mean the Great Rate Debate is settled.
TLT And SCHQ - Potential Confirmation And Low-Cost Play
09:00am, Thursday, 13'th Jun 2024
Recent economic data supports a bullish view of long-term US bonds. The structural argument for high debt and deficit sustainability driving thesis. Introduction of a low-cost alternative to TLT - Sch
Ruvidar(TM) Enhances Efficacy of Cancer Drug
07:00am, Monday, 10'th Jun 2024
TORONTO, ON / ACCESSWIRE / June 10, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and
